The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Iduronate 2 Sulfatase Market Research Report 2025
Synopsis
Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes.
The global Iduronate 2 Sulfatase market was valued at US$ 914 million in 2023 and is anticipated to reach US$ 1295.1 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
Iduronate 2-sulfatase (IDS) is a sulfatase enzyme associated with Hunter syndrome. Iduronate 2-sulfatase is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this X-chromosome gene that result in enzymatic deficiency lead to Hunter syndrome.
This report aims to provide a comprehensive presentation of the global market for Iduronate 2 Sulfatase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iduronate 2 Sulfatase.
Report Scope
The Iduronate 2 Sulfatase market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Iduronate 2 Sulfatase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iduronate 2 Sulfatase companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AngioChem
ArmaGen
Bioasis Technologies
Green Cross
JCR Pharmaceuticals
Esteve
RegenxBio
Sangamo BioSciences
Takeda
Segment by Type
Alpha L Iduronate Sulfate Sulfatase
Idursulfase
IDS
EC 3.1.6.13
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Iduronate 2 Sulfatase companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes.
The global Iduronate 2 Sulfatase market was valued at US$ 914 million in 2023 and is anticipated to reach US$ 1295.1 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
Iduronate 2-sulfatase (IDS) is a sulfatase enzyme associated with Hunter syndrome. Iduronate 2-sulfatase is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this X-chromosome gene that result in enzymatic deficiency lead to Hunter syndrome.
This report aims to provide a comprehensive presentation of the global market for Iduronate 2 Sulfatase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iduronate 2 Sulfatase.
Report Scope
The Iduronate 2 Sulfatase market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Iduronate 2 Sulfatase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iduronate 2 Sulfatase companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AngioChem
ArmaGen
Bioasis Technologies
Green Cross
JCR Pharmaceuticals
Esteve
RegenxBio
Sangamo BioSciences
Takeda
Segment by Type
Alpha L Iduronate Sulfate Sulfatase
Idursulfase
IDS
EC 3.1.6.13
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Iduronate 2 Sulfatase companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Iduronate 2 Sulfatase Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Alpha L Iduronate Sulfate Sulfatase
1.2.3 Idursulfase
1.2.4 IDS
1.2.5 EC 3.1.6.13
1.3 Market by Application
1.3.1 Global Iduronate 2 Sulfatase Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Iduronate 2 Sulfatase Market Perspective (2019-2030)
2.2 Iduronate 2 Sulfatase Growth Trends by Region
2.2.1 Global Iduronate 2 Sulfatase Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Iduronate 2 Sulfatase Historic Market Size by Region (2019-2024)
2.2.3 Iduronate 2 Sulfatase Forecasted Market Size by Region (2025-2030)
2.3 Iduronate 2 Sulfatase Market Dynamics
2.3.1 Iduronate 2 Sulfatase Industry Trends
2.3.2 Iduronate 2 Sulfatase Market Drivers
2.3.3 Iduronate 2 Sulfatase Market Challenges
2.3.4 Iduronate 2 Sulfatase Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Iduronate 2 Sulfatase Players by Revenue
3.1.1 Global Top Iduronate 2 Sulfatase Players by Revenue (2019-2024)
3.1.2 Global Iduronate 2 Sulfatase Revenue Market Share by Players (2019-2024)
3.2 Global Iduronate 2 Sulfatase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Iduronate 2 Sulfatase Revenue
3.4 Global Iduronate 2 Sulfatase Market Concentration Ratio
3.4.1 Global Iduronate 2 Sulfatase Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Iduronate 2 Sulfatase Revenue in 2023
3.5 Iduronate 2 Sulfatase Key Players Head office and Area Served
3.6 Key Players Iduronate 2 Sulfatase Product Solution and Service
3.7 Date of Enter into Iduronate 2 Sulfatase Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Iduronate 2 Sulfatase Breakdown Data by Type
4.1 Global Iduronate 2 Sulfatase Historic Market Size by Type (2019-2024)
4.2 Global Iduronate 2 Sulfatase Forecasted Market Size by Type (2025-2030)
5 Iduronate 2 Sulfatase Breakdown Data by Application
5.1 Global Iduronate 2 Sulfatase Historic Market Size by Application (2019-2024)
5.2 Global Iduronate 2 Sulfatase Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Iduronate 2 Sulfatase Market Size (2019-2030)
6.2 North America Iduronate 2 Sulfatase Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Iduronate 2 Sulfatase Market Size by Country (2019-2024)
6.4 North America Iduronate 2 Sulfatase Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Iduronate 2 Sulfatase Market Size (2019-2030)
7.2 Europe Iduronate 2 Sulfatase Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Iduronate 2 Sulfatase Market Size by Country (2019-2024)
7.4 Europe Iduronate 2 Sulfatase Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Iduronate 2 Sulfatase Market Size (2019-2030)
8.2 Asia-Pacific Iduronate 2 Sulfatase Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Iduronate 2 Sulfatase Market Size by Region (2019-2024)
8.4 Asia-Pacific Iduronate 2 Sulfatase Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Iduronate 2 Sulfatase Market Size (2019-2030)
9.2 Latin America Iduronate 2 Sulfatase Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Iduronate 2 Sulfatase Market Size by Country (2019-2024)
9.4 Latin America Iduronate 2 Sulfatase Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Iduronate 2 Sulfatase Market Size (2019-2030)
10.2 Middle East & Africa Iduronate 2 Sulfatase Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Iduronate 2 Sulfatase Market Size by Country (2019-2024)
10.4 Middle East & Africa Iduronate 2 Sulfatase Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AngioChem
11.1.1 AngioChem Company Detail
11.1.2 AngioChem Business Overview
11.1.3 AngioChem Iduronate 2 Sulfatase Introduction
11.1.4 AngioChem Revenue in Iduronate 2 Sulfatase Business (2019-2024)
11.1.5 AngioChem Recent Development
11.2 ArmaGen
11.2.1 ArmaGen Company Detail
11.2.2 ArmaGen Business Overview
11.2.3 ArmaGen Iduronate 2 Sulfatase Introduction
11.2.4 ArmaGen Revenue in Iduronate 2 Sulfatase Business (2019-2024)
11.2.5 ArmaGen Recent Development
11.3 Bioasis Technologies
11.3.1 Bioasis Technologies Company Detail
11.3.2 Bioasis Technologies Business Overview
11.3.3 Bioasis Technologies Iduronate 2 Sulfatase Introduction
11.3.4 Bioasis Technologies Revenue in Iduronate 2 Sulfatase Business (2019-2024)
11.3.5 Bioasis Technologies Recent Development
11.4 Green Cross
11.4.1 Green Cross Company Detail
11.4.2 Green Cross Business Overview
11.4.3 Green Cross Iduronate 2 Sulfatase Introduction
11.4.4 Green Cross Revenue in Iduronate 2 Sulfatase Business (2019-2024)
11.4.5 Green Cross Recent Development
11.5 JCR Pharmaceuticals
11.5.1 JCR Pharmaceuticals Company Detail
11.5.2 JCR Pharmaceuticals Business Overview
11.5.3 JCR Pharmaceuticals Iduronate 2 Sulfatase Introduction
11.5.4 JCR Pharmaceuticals Revenue in Iduronate 2 Sulfatase Business (2019-2024)
11.5.5 JCR Pharmaceuticals Recent Development
11.6 Esteve
11.6.1 Esteve Company Detail
11.6.2 Esteve Business Overview
11.6.3 Esteve Iduronate 2 Sulfatase Introduction
11.6.4 Esteve Revenue in Iduronate 2 Sulfatase Business (2019-2024)
11.6.5 Esteve Recent Development
11.7 RegenxBio
11.7.1 RegenxBio Company Detail
11.7.2 RegenxBio Business Overview
11.7.3 RegenxBio Iduronate 2 Sulfatase Introduction
11.7.4 RegenxBio Revenue in Iduronate 2 Sulfatase Business (2019-2024)
11.7.5 RegenxBio Recent Development
11.8 Sangamo BioSciences
11.8.1 Sangamo BioSciences Company Detail
11.8.2 Sangamo BioSciences Business Overview
11.8.3 Sangamo BioSciences Iduronate 2 Sulfatase Introduction
11.8.4 Sangamo BioSciences Revenue in Iduronate 2 Sulfatase Business (2019-2024)
11.8.5 Sangamo BioSciences Recent Development
11.9 Takeda
11.9.1 Takeda Company Detail
11.9.2 Takeda Business Overview
11.9.3 Takeda Iduronate 2 Sulfatase Introduction
11.9.4 Takeda Revenue in Iduronate 2 Sulfatase Business (2019-2024)
11.9.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Iduronate 2 Sulfatase Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Alpha L Iduronate Sulfate Sulfatase
Table 3. Key Players of Idursulfase
Table 4. Key Players of IDS
Table 5. Key Players of EC 3.1.6.13
Table 6. Global Iduronate 2 Sulfatase Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Iduronate 2 Sulfatase Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Iduronate 2 Sulfatase Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Iduronate 2 Sulfatase Market Share by Region (2019-2024)
Table 10. Global Iduronate 2 Sulfatase Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Iduronate 2 Sulfatase Market Share by Region (2025-2030)
Table 12. Iduronate 2 Sulfatase Market Trends
Table 13. Iduronate 2 Sulfatase Market Drivers
Table 14. Iduronate 2 Sulfatase Market Challenges
Table 15. Iduronate 2 Sulfatase Market Restraints
Table 16. Global Iduronate 2 Sulfatase Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Iduronate 2 Sulfatase Market Share by Players (2019-2024)
Table 18. Global Top Iduronate 2 Sulfatase Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iduronate 2 Sulfatase as of 2023)
Table 19. Ranking of Global Top Iduronate 2 Sulfatase Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Iduronate 2 Sulfatase Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Iduronate 2 Sulfatase Product Solution and Service
Table 23. Date of Enter into Iduronate 2 Sulfatase Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Iduronate 2 Sulfatase Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Iduronate 2 Sulfatase Revenue Market Share by Type (2019-2024)
Table 27. Global Iduronate 2 Sulfatase Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Iduronate 2 Sulfatase Revenue Market Share by Type (2025-2030)
Table 29. Global Iduronate 2 Sulfatase Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Iduronate 2 Sulfatase Revenue Market Share by Application (2019-2024)
Table 31. Global Iduronate 2 Sulfatase Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Iduronate 2 Sulfatase Revenue Market Share by Application (2025-2030)
Table 33. North America Iduronate 2 Sulfatase Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Iduronate 2 Sulfatase Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Iduronate 2 Sulfatase Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Iduronate 2 Sulfatase Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Iduronate 2 Sulfatase Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Iduronate 2 Sulfatase Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Iduronate 2 Sulfatase Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Iduronate 2 Sulfatase Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Iduronate 2 Sulfatase Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Iduronate 2 Sulfatase Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Iduronate 2 Sulfatase Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Iduronate 2 Sulfatase Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Iduronate 2 Sulfatase Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Iduronate 2 Sulfatase Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Iduronate 2 Sulfatase Market Size by Country (2025-2030) & (US$ Million)
Table 48. AngioChem Company Detail
Table 49. AngioChem Business Overview
Table 50. AngioChem Iduronate 2 Sulfatase Product
Table 51. AngioChem Revenue in Iduronate 2 Sulfatase Business (2019-2024) & (US$ Million)
Table 52. AngioChem Recent Development
Table 53. ArmaGen Company Detail
Table 54. ArmaGen Business Overview
Table 55. ArmaGen Iduronate 2 Sulfatase Product
Table 56. ArmaGen Revenue in Iduronate 2 Sulfatase Business (2019-2024) & (US$ Million)
Table 57. ArmaGen Recent Development
Table 58. Bioasis Technologies Company Detail
Table 59. Bioasis Technologies Business Overview
Table 60. Bioasis Technologies Iduronate 2 Sulfatase Product
Table 61. Bioasis Technologies Revenue in Iduronate 2 Sulfatase Business (2019-2024) & (US$ Million)
Table 62. Bioasis Technologies Recent Development
Table 63. Green Cross Company Detail
Table 64. Green Cross Business Overview
Table 65. Green Cross Iduronate 2 Sulfatase Product
Table 66. Green Cross Revenue in Iduronate 2 Sulfatase Business (2019-2024) & (US$ Million)
Table 67. Green Cross Recent Development
Table 68. JCR Pharmaceuticals Company Detail
Table 69. JCR Pharmaceuticals Business Overview
Table 70. JCR Pharmaceuticals Iduronate 2 Sulfatase Product
Table 71. JCR Pharmaceuticals Revenue in Iduronate 2 Sulfatase Business (2019-2024) & (US$ Million)
Table 72. JCR Pharmaceuticals Recent Development
Table 73. Esteve Company Detail
Table 74. Esteve Business Overview
Table 75. Esteve Iduronate 2 Sulfatase Product
Table 76. Esteve Revenue in Iduronate 2 Sulfatase Business (2019-2024) & (US$ Million)
Table 77. Esteve Recent Development
Table 78. RegenxBio Company Detail
Table 79. RegenxBio Business Overview
Table 80. RegenxBio Iduronate 2 Sulfatase Product
Table 81. RegenxBio Revenue in Iduronate 2 Sulfatase Business (2019-2024) & (US$ Million)
Table 82. RegenxBio Recent Development
Table 83. Sangamo BioSciences Company Detail
Table 84. Sangamo BioSciences Business Overview
Table 85. Sangamo BioSciences Iduronate 2 Sulfatase Product
Table 86. Sangamo BioSciences Revenue in Iduronate 2 Sulfatase Business (2019-2024) & (US$ Million)
Table 87. Sangamo BioSciences Recent Development
Table 88. Takeda Company Detail
Table 89. Takeda Business Overview
Table 90. Takeda Iduronate 2 Sulfatase Product
Table 91. Takeda Revenue in Iduronate 2 Sulfatase Business (2019-2024) & (US$ Million)
Table 92. Takeda Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Iduronate 2 Sulfatase Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Iduronate 2 Sulfatase Market Share by Type: 2023 VS 2030
Figure 3. Alpha L Iduronate Sulfate Sulfatase Features
Figure 4. Idursulfase Features
Figure 5. IDS Features
Figure 6. EC 3.1.6.13 Features
Figure 7. Global Iduronate 2 Sulfatase Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Iduronate 2 Sulfatase Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Iduronate 2 Sulfatase Report Years Considered
Figure 13. Global Iduronate 2 Sulfatase Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Iduronate 2 Sulfatase Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Iduronate 2 Sulfatase Market Share by Region: 2023 VS 2030
Figure 16. Global Iduronate 2 Sulfatase Market Share by Players in 2023
Figure 17. Global Top Iduronate 2 Sulfatase Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iduronate 2 Sulfatase as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Iduronate 2 Sulfatase Revenue in 2023
Figure 19. North America Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Iduronate 2 Sulfatase Market Share by Country (2019-2030)
Figure 21. United States Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Iduronate 2 Sulfatase Market Share by Country (2019-2030)
Figure 25. Germany Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Iduronate 2 Sulfatase Market Share by Region (2019-2030)
Figure 33. China Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Iduronate 2 Sulfatase Market Share by Country (2019-2030)
Figure 41. Mexico Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Iduronate 2 Sulfatase Market Share by Country (2019-2030)
Figure 45. Turkey Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Iduronate 2 Sulfatase Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. AngioChem Revenue Growth Rate in Iduronate 2 Sulfatase Business (2019-2024)
Figure 48. ArmaGen Revenue Growth Rate in Iduronate 2 Sulfatase Business (2019-2024)
Figure 49. Bioasis Technologies Revenue Growth Rate in Iduronate 2 Sulfatase Business (2019-2024)
Figure 50. Green Cross Revenue Growth Rate in Iduronate 2 Sulfatase Business (2019-2024)
Figure 51. JCR Pharmaceuticals Revenue Growth Rate in Iduronate 2 Sulfatase Business (2019-2024)
Figure 52. Esteve Revenue Growth Rate in Iduronate 2 Sulfatase Business (2019-2024)
Figure 53. RegenxBio Revenue Growth Rate in Iduronate 2 Sulfatase Business (2019-2024)
Figure 54. Sangamo BioSciences Revenue Growth Rate in Iduronate 2 Sulfatase Business (2019-2024)
Figure 55. Takeda Revenue Growth Rate in Iduronate 2 Sulfatase Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
